company background image
BNKL logo

Bionik Laboratories OTCPK:BNKL Stock Report

Last Price

US$0.000001

Market Cap

US$12.0

7D

0%

1Y

n/a

Updated

19 Dec, 2024

Data

Company Financials

Bionik Laboratories Corp.

OTCPK:BNKL Stock Report

Market Cap: US$12.0

BNKL Stock Overview

A robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. More details

BNKL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Bionik Laboratories Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bionik Laboratories
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

BNKLUS Medical EquipmentUS Market
7D0%-3.4%-3.5%
1Yn/a9.0%22.1%

Return vs Industry: Insufficient data to determine how BNKL performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how BNKL performed against the US Market.

Price Volatility

Is BNKL's price volatile compared to industry and market?
BNKL volatility
BNKL Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: BNKL's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BNKL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201012Rich Russowww.bioniklabs.com

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Bionik Laboratories Corp. Fundamentals Summary

How do Bionik Laboratories's earnings and revenue compare to its market cap?
BNKL fundamental statistics
Market capUS$12.00
Earnings (TTM)-US$4.95m
Revenue (TTM)US$1.81m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BNKL income statement (TTM)
RevenueUS$1.81m
Cost of RevenueUS$815.33k
Gross ProfitUS$989.88k
Other ExpensesUS$5.94m
Earnings-US$4.95m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did BNKL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 00:14
End of Day Share Price 2024/12/02 00:00
Earnings2023/03/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bionik Laboratories Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian MarckxZacks Investment Research Inc.